BioAgilytix CFO Todd Lynch Named to 2017 Class of CFO of the Year Award Winners by Triangle Business Journal

Lynch Recognized for Strategic Leadership During BioAgilytix’s Exceptional Growth

June 12, 2017—Durham, NC—BioAgilytix, a leading provider of contract bioanalytical testing services with specialization in large molecule bioanalysis, has announced that the company’s Senior Vice President & Chief Financial Officer, Todd Lynch, was named a winner in the Triangle Business Journal’s 2017 CFO of the Year Awards. These awards recognize outstanding financial executives who exemplify excellence as corporate financial stewards.

Mr. Lynch’s appearance on this list demonstrates his and BioAgilytix’s commitment to fiscally responsible growth. Over the past year and a half, BioAgilytix has expanded operations into Europe through the acquisition of IPM Biotech, a leading German-based bioanalytical laboratory supporting large molecule bioanalysis; opened a new state-of-the-art laboratory facility for its new subsidiary in Hamburg, Germany; and completed a 19,000+ sq. ft. build-out of its USA laboratory in the RTP area to bring the total footprint to more than 48,000 sq. ft. Throughout this time, Lynch was a prominent voice in assuring growth was systematic, measured, and financially successful.

“Todd is an extremely valuable member of our leadership team at BioAgilytix, and we are excited to see his work recognized with the TBJ’s CFO of the Year award,” said Jim Datin, Chief Executive Officer of BioAgilytix. “He brings to BioAgilytix an invaluable perspective gained from more than 23 years working with biotechnology, big pharma, clinical diagnostics, and contract research organizations at various stages of growth. With his seasoned insights and fiscal guidance we have been able to scale effectively while continuing to serve our customers with the highest levels of science, service, and quality.”

“I am proud to be part of an organization that is so passionate about fulfilling its mission to improve human health,” said Lynch. “It has been great to play an integral part in BioAgilytix’s recent achievements, and I’m excited about our future as we continue this exciting time of growth.”

Mr. Lynch, along with the ten other winners of this year’s awards, will be honored at a celebratory luncheon on July 13 at Prestonwood Country Club in Cary, North Carolina.


About BioAgilytix

BioAgilytix is a leading global bioanalytical testing laboratory specializing in large molecule bioanalysis. With laboratory locations in North Carolina’s Research Triangle area and Hamburg, Germany, BioAgilytix provides PK, immunogenicity, biomarkers, and cell-based assay services supporting the development and release testing of biologics across a number of industries and disease states. BioAgilytix offers assay development, validation, and sample analysis under non-GLP, spirit-of-GLP, GLP, and GCP, as well as product release testing under GMP./p>

BioAgilytix’s team of highly experienced scientific and QA professionals ensures high quality science, data integrity, and regulatory compliance through all phases of clinical development, and is a trusted partner to 23 of the top 25 global pharmaceutical and biotech companies. For more information, visit

Media Contact:
Jennifer Absher
(919) 287-1573
[email protected]

Featured Expert

Pharmacokinetics & Pharmacodynamics​

See how our PK expertise complements our immunogenicity services by evaluating absorption, distribution, metabolism and excretion characteristics of a product.
220328 Adleverage_Scientific Icon Illustrations_#46-65_CO_Per FIles